...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis
【24h】

Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis

机译:导管定向溶栓治疗近端深静脉血栓形成的早期和长期疗效的决定因素

获取原文
获取原文并翻译 | 示例

摘要

Purpose: Catheter-directed thrombolysis (CDT) for proximal deep vein thrombosis (DVT) effectively enhances clot removal and recently has been shown to reduce the development of postthrombotic syndrome (PTS). This study was performed to identify potential markers for early and long-term efficacy of CDT, adverse events, and their interrelationship. Materials and Methods: Patients aged 18-75 years (mean, 54 y; 33 women) with first-time proximal DVT and symptoms up to 21 days were included in subanalyses in an open, multicenter, randomized, controlled trial. Early efficacy was assessed with a thrombus score based on daily venography. Six-month and 2-year follow-up included iliofemoral patency assessed with duplex ultrasound and air plethysmography, and PTS was assessed with the Villalta scale. Results: A mean clot resolution of 82%??25 was achieved in 92 patients. Successful lysis (ie,??50%) was obtained in 83 patients. Early efficacy was equal for femoral and iliofemoral thrombus and not related to thrombus load before CDT, symptom duration, or predisposing risk factors. Lower thrombus score at completion of CDT was associated with increased patency at 24 months (P =.040), and increased patency after 6 and 24 months was correlated with reduced development of PTS after 24 months (P<.001). Bleeding complications were mainly related to the puncture site, and popliteal vein access led to fewer bleeding incidents. Conclusions: Comp, this is a Clinical Study article, so, as noted on the TOC, the Conclusions section of the abstract gets listed on the TOC. CDT via popliteal access was safe, effectively removed clots, and restored iliofemoral patency. Preprocedure evaluation did not identify patients who did not benefit from treatment. Early efficacy and follow-up patency are of importance to reduce the risk for PTS. ? 2013 SIR.
机译:目的:针对近端深静脉血栓形成(DVT)的导管定向溶栓术(CDT)有效地增强了血凝块清除作用,最近已证明可减少血栓形成后综合征(PTS)的发展。进行这项研究以鉴定CDT早期和长期疗效,不良事件及其相互关系的潜在标志物。资料和方法:一项开放,多中心,随机,对照试验的亚组分析包括年龄在18-75岁(平均54岁; 33名女性)的首次近端DVT且症状长达21天的患者。根据每日静脉造影的血栓评分评估早期疗效。六个月和两年的随访包括通过双工超声和空气体积描记法评估的of股通畅性,并使用Villalta量表评估PTS。结果:92例患者的平均凝块分辨率达到82%?? 25。 83例患者获得了成功的裂解(即50%)。股骨和股血栓的早期疗效相同,与CDT之前的血栓负荷,症状持续时间或易感危险因素无关。 CDT完成时较低的血栓评分与24个月通畅性增加相关(P = .040),而6和24个月后通畅性增加与24个月后PTS发生减少相关(P <.001)。出血并发症主要与穿刺部位有关,pop静脉接入导致出血事件减少。结论:对不起,这是一篇临床研究文章,因此,如TOC所述,摘要的结论部分将列在TOC上。通过pop骨通路的CDT是安全的,可以有效去除血块并恢复股通畅。术前评估未发现不能从治疗中受益的患者。早期疗效和后续通畅对于降低PTS风险非常重要。 ? 2013年SIR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号